by Diego Morales | Sep 27, 2024 | Product Development
Are you a CPG formulator or product developer seeking to innovate with minor and rare cannabinoids? This comprehensive guide covers everything you need to know, from understanding these potent compounds to sourcing high-quality ingredients from reputable cannabinoid...
by Diego Morales | Sep 27, 2024 | Industry
Are you wondering which fall cannabis industry events you should attend in 2024? This guide covers all the essential cannabis events, trade shows, conferences, and expos you must mark on your calendar. From networking opportunities to the latest industry trends,...
by Diego Morales | Sep 27, 2024 | Uncategorized
In the rapidly evolving world of cannabinoid-based products, nature-identical synthesized cannabinoids are often misunderstood. As CPG product developers, understanding the facts behind these misconceptions can be crucial in making informed decisions that align with...
by Diego Morales | Sep 23, 2024 | CBC
Cannabichromene (CBC) is a key non-psychoactive component of cannabis, noted for its potential benefits. This article dives into what CBC is, its properties, and its possible consumer applications. Key Takeaways Cannabichromene (CBC) is a non-psychotropic cannabinoid...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Research
The cannabis industry has moved one step closer to discovering the perfect, non-intoxicating therapeutic solution for bodily discomfort. Recent findings from a groundbreaking study on the effects of CBD and minor cannabinoids on pain, conducted by Radicle Science in...
Recent Comments